Treace John T.
Executive buyerDirector, Chief Executive Officer, 10% Owner · TREACE MEDICAL CONCEPTS, INC.
Every open-market stock purchase Treace John T. has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.
Where the buys stand today
- TMCITREACE MEDICAL CONCEPTS, INC.
17 purchases totalling $5.4M at an average of $4.72 per share. See all insider buying in TMCI →
Avg price paid$4.72Latest price—Market capUnknown
Cluster participation
Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.
All reported buys
| Date | Ticker | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Aug 24, 2026 | 11,000 | $4.34 | $47.7K | SEC ↗ | |
| Aug 21, 2026 | 5,000 | $4.35 | $21.7K | SEC ↗ | |
| Aug 20, 2026 | 39,944 | $4.44 | $177.2K | SEC ↗ | |
| Jun 10, 2026 | 29,430 | $4.02 | $118.4K | SEC ↗ | |
| Jun 1, 2026 | 50,000 | $3.56 | $177.9K | SEC ↗ | |
| May 28, 2026 | 61,202 | $3.02 | $184.8K | SEC ↗ | |
| May 27, 2026 | 49,810 | $2.87 | $143.2K | SEC ↗ | |
| May 14, 2026 | 61,750 | $2.62 | $161.5K | SEC ↗ | |
| May 13, 2026 | 49,013 | $2.46 | $120.5K | SEC ↗ | |
| Mar 4, 2025 | 60,000 | $8.73 | $523.8K | SEC ↗ | |
| Sep 16, 2024 | 50,000 | $5.31 | $265.5K | SEC ↗ | |
| Aug 14, 2024 | TMCIcluster | 85,000 | $6.00 | $510.0K | SEC ↗ |
| Jun 11, 2024 | TMCIcluster | 45,000 | $5.88 | $264.6K | SEC ↗ |
| May 17, 2024 | TMCIcluster | 100,000 | $5.56 | $556.0K | SEC ↗ |
| May 14, 2024 | TMCIcluster | 150,000 | $5.12 | $768.0K | SEC ↗ |
| May 13, 2024 | TMCIcluster | 150,000 | $4.56 | $684.0K | SEC ↗ |
| May 10, 2024 | TMCIcluster | 150,000 | $4.58 | $687.0K | SEC ↗ |
Follow new qualifying clusters involving Treace John T. or other insiders
Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.
About this data
Figures are parsed from Treace John T.'s Form 4 filings on SEC EDGAR (CIK 1856380) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.